Invited Papers (Oral) [1-page]
08:00 - 08:45 | Wed 12 Jul | Dunn Room | WeAT13
A liquid-gallium based nanoformulation is developed for co-delivery of a membrane-associated cytokine (TRAIL) and an intracellular-acting small-molecule drug (CDDP) to overcome drug-resistance in cancer cells. This fully biodegradable nanocarrier could intracellularly transform into therapeutic agent Ga (III) ions to facilitate to reverse drug resistance and to promote anticancer efficacy.
No information added